Back to Search
Start Over
Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report.
- Source :
-
Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Apr 06; Vol. 113 (4), pp. 481-495. - Publication Year :
- 2021
-
Abstract
- Background: Survivors of childhood acute myeloid leukemia (AML) are vulnerable to medical late effects of treatment; however, less is known about their psychosocial outcomes. This study evaluated neurocognitive and psychosocial outcomes in long-term AML survivors treated with bone marrow transplantation (BMT) or intensive chemotherapy (IC) without BMT.<br />Methods: AML survivors (N = 482; median age at diagnosis = 8 [range = 0-20] years; median age at evaluation = 30 [range = 18-49] years) treated with BMT (n = 183) or IC (n = 299) and sibling controls (N = 3190; median age at evaluation = 32 [range = 18-58] years) from the Childhood Cancer Survivor Study were compared on emotional distress (Brief Symptom Inventory-18), neurocognitive problems (Childhood Cancer Survivor Study Neurocognitive Questionnaire), health-related quality of life (SF-36), and social attainment. Outcomes were dichotomized (impaired vs nonimpaired) using established criteria, and relative risks (RRs) were estimated with multivariable Poisson regression, adjusted for age at evaluation and sex.<br />Results: AML survivors were more likely than siblings to report impairment in overall emotional (RR = 2.19, 95% confidence interval [CI] = 1.51 to 3.18), neurocognitive (RR = 2.03, 95% CI = 1.47 to 2.79), and physical quality of life (RR = 2.71, 95% CI = 1.61 to 4.56) outcomes. Survivors were at increased risk for lower education (RR = 1.15, 95% CI = 1.03 to 1.30), unemployment (RR = 1.41, 95% CI = 1.16 to 1.71), lower income (RR = 1.39, 95% CI = 1.17 to 1.65), and not being married or having a partner (RR = 1.33, 95% CI = 1.17 to 1.51). BMT-treated survivors did not differ statistically significantly from IC-treated on any outcome measure.<br />Conclusions: AML survivors are at increased risk for psychosocial impairment compared with siblings; however, BMT does not confer additional risk for psychosocial late effects compared with treatment without BMT.<br /> (© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Subjects :
- Adolescent
Adult
Age Factors
Bone Marrow Transplantation
Child
Child, Preschool
Confidence Intervals
Educational Status
Female
Humans
Infant
Infant, Newborn
Leukemia, Myeloid, Acute drug therapy
Leukemia, Myeloid, Acute surgery
Male
Marital Status
Middle Aged
Outcome Assessment, Health Care
Psychological Distance
Psychological Distress
Quality of Life
Sex Factors
Siblings
Unemployment
Young Adult
Cancer Survivors psychology
Leukemia, Myeloid, Acute psychology
Neurocognitive Disorders etiology
Socioeconomic Factors
Subjects
Details
- Language :
- English
- ISSN :
- 1460-2105
- Volume :
- 113
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Journal of the National Cancer Institute
- Publication Type :
- Academic Journal
- Accession number :
- 32797189
- Full Text :
- https://doi.org/10.1093/jnci/djaa102